Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Liver Diseases

Free Subscription 14.11.2022 1 Am J Pathol 1 Biochem Biophys Res Commun 1 BMC Cancer 3 BMC Gastroenterol 8 Clin Res Hepatol Gastroenterol 1 Dig Dis Sci 1 Gastroenterology 4 Gut 1 Indian J Gastroenterol 2 J Gastroenterol Hepatol 3 J Hepatol 1 PLoS One 5 Transplant Proc

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am J Pathol

1. HURLEY EH, Tao J, Liu S, Krutsenko Y, et al
   Inhibition of HSF1 Signaling Decreases Hepatoblastoma Growth Via Induction of Apoptosis.
   Am J Pathol. 2022 Nov 3. pii: S0002-9440(22)00355.
   PubMed         Abstract available
   
   

   
   Biochem Biophys Res Commun

2. NTAMBI JM
   The role of Stearoyl-CoA desaturase in hepatic de novo lipogenesis.
   Biochem Biophys Res Commun. 2022;633:81-83.
   PubMed         Abstract available
   
   

   
   BMC Cancer

3. CHEN YH, Wang CC, Chen YY, Wang JH, et al
   Low-dose nivolumab in advanced hepatocellular carcinoma.
   BMC Cancer. 2022;22:1153.
   PubMed         Abstract available
   
   

   
   BMC Gastroenterol

4. LI R, Jin C, Zhao W, Liang R, et al
   Development of a novel immune-related lncRNA prognostic signature for patients with hepatocellular carcinoma.
   BMC Gastroenterol. 2022;22:450.
   PubMed         Abstract available
   
   
5. SEEBERG KA, Hofso D, Borgeraas H, Grimnes JO, et al
   Association between hepatic steatosis and fibrosis with measures of insulin sensitivity in patients with severe obesity and type 2 diabetes - a cross-sectional study.
   BMC Gastroenterol. 2022;22:448.
   PubMed         Abstract available
   
   
6. ZHANG D, Li Q, Li D, Jia J, et al
   Stereotactic body radiation therapy as an effective local treatment for advanced hepatocellular carcinoma patients with inferior vena cava and right atrial tumor thrombus.
   BMC Gastroenterol. 2022;22:451.
   PubMed         Abstract available
   
   

   
   Clin Res Hepatol Gastroenterol

7. LI N, Yang P, Fang J
   Transarterial chemoembolization (TACE) plus apatinib vs. TACE alone for hepatocellular carcinoma.
   Clin Res Hepatol Gastroenterol. 2022;46:102022.
   PubMed         Abstract available
   
   
8. WASUWANICH P, Choudry H, So JM, Lowry S, et al
   Vanishing bile duct syndrome after drug-induced liver injury.
   Clin Res Hepatol Gastroenterol. 2022;46:102015.
   PubMed         Abstract available
   
   
9. SHARMA D, Mandal P
   NAFLD: genetics and its clinical implications.
   Clin Res Hepatol Gastroenterol. 2022;46:102003.
   PubMed         Abstract available
   
   
10. WU L, Yang J, Ke RS, Liu Y, et al
    Impact of lncRNA SOX9-AS1 overexpression on the prognosis and progression of intrahepatic cholangiocarcinoma.
    Clin Res Hepatol Gastroenterol. 2022;46:101999.
    PubMed         Abstract available
    
    
11. ISSA Z, Gohy S, Zech F, Baldin P, et al
    Prevalence and characteristics of cystic fibrosis liver disease: a study highlighting the lack of histological diagnosis.
    Clin Res Hepatol Gastroenterol. 2022;46:101977.
    PubMed         Abstract available
    
    
12. FANG Z, Yang H, Mao Y
    Letter to the editor: Liver transarterial chemoembolization plus sunitinib for unresectable hepatocellular carcinoma.
    Clin Res Hepatol Gastroenterol. 2022;46:101984.
    PubMed        
    
    
13. GUILLAUD O, Woimant F, Couchonnal E, Dumortier J, et al
    Maintenance therapy simplification using a single daily dose: A preliminary real-life feasibility study in patients with Wilson disease.
    Clin Res Hepatol Gastroenterol. 2022;46:101978.
    PubMed         Abstract available
    
    
14. BOUZBIB C, El Mourabit H, Wendum D, Lasnier E, et al
    ATP-binding cassette transporters expression in rats with cirrhosis and hepatic encephalopathy.
    Clin Res Hepatol Gastroenterol. 2021 Aug 9:101784.
    PubMed         Abstract available
    
    

    
    Dig Dis Sci

15. INOUE T, Kitano R, Ibusuki M, Sakamoto K, et al
    Endoscopic Ultrasound-Guided Hepaticogastrostomy with Antegrade Stenting Without Dilation Device Application for Malignant Distal Biliary Obstruction in Pancreatic Cancer.
    Dig Dis Sci. 2022 Nov 9. pii: 10.1007/s10620-022-07749.
    PubMed         Abstract available
    
    

    
    Gastroenterology

16. BRANDI G, Tovoli F, Tavolari S
    Have We Found the "Holy Grail" That May Predict Response to Immunotherapy in Hepatocellular Carcinoma?
    Gastroenterology. 2022 Nov 4. pii: S0016-5085(22)01252.
    PubMed        
    
    

    
    Gut

17. BAJAJ JS, Pena-Rodriguez M, La Reau A, Phillips W, et al
    Longitudinal transkingdom gut microbial approach towards decompensation in outpatients with cirrhosis.
    Gut. 2022 Nov 7. pii: gutjnl-2022-328403. doi: 10.1136/gutjnl-2022-328403.
    PubMed         Abstract available
    
    
18. TIAN S, Chu Y, Hu J, Ding X, et al
    Tumour-associated neutrophils secrete AGR2 to promote colorectal cancer metastasis via its receptor CD98hc-xCT.
    Gut. 2022 Jan 27. pii: gutjnl-2021-325137. doi: 10.1136/gutjnl-2021-325137.
    PubMed         Abstract available
    
    
19. RAO J, Wang H, Ni M, Wang Z, et al
    FSTL1 promotes liver fibrosis by reprogramming macrophage function through modulating the intracellular function of PKM2.
    Gut. 2022;71:2539-2550.
    PubMed         Abstract available
    
    
20. LATIF MU, Schmidt GE, Mercan S, Rahman R, et al
    NFATc1 signaling drives chronic ER stress responses to promote NAFLD progression.
    Gut. 2022;71:2561-2573.
    PubMed         Abstract available
    
    

    
    Indian J Gastroenterol

21. KUMAR VV, Kothakota SR, Nair AK, Sasidharan M, et al
    Impact of sarcopenia on post-liver transplant morbidity and mortality in cirrhotic patients.
    Indian J Gastroenterol. 2022 Nov 7. pii: 10.1007/s12664-022-01262.
    PubMed         Abstract available
    
    

    
    J Gastroenterol Hepatol

22. OUYANG R, Li H, Tan W, Wang X, et al
    Portal vein thrombosis compromises the performance of MELD and MELD-Na scores in patients with cirrhosis.
    J Gastroenterol Hepatol. 2022 Nov 7. doi: 10.1111/jgh.16053.
    PubMed         Abstract available
    
    
23. KARAGIANNAKIS DS, Voulgaris T, Markakis G, Lakiotaki D, et al
    Spleen stiffness can predict liver decompensation and survival in patients with cirrhosis.
    J Gastroenterol Hepatol. 2022 Nov 8. doi: 10.1111/jgh.16057.
    PubMed         Abstract available
    
    

    
    J Hepatol

24. TRANAH TH, Ballester MP, Carbonell-Asins JA, Jalan R, et al
    Reply to 'Ammonia and prognosis of cirrhosis: a new perspective for identifying high risk patients'.
    J Hepatol. 2022 Nov 2. pii: S0168-8278(22)03162.
    PubMed        
    
    
25. RATZIU V, Harrison SA, Loustaud-Ratti V, Bureau C, et al
    Hepatic and renal improvements with FXR agonist vonafexor in individuals with suspected fibrotic NASH.
    J Hepatol. 2022 Nov 2. pii: S0168-8278(22)03160.
    PubMed         Abstract available
    
    
26. KUDO M, Finn RS, Qin S, Han KH, et al
    Overall survival and objective response in advanced unresectable hepatocellular carcinoma: A subanalysis of the REFLECT study.
    J Hepatol. 2022 Sep 20. pii: S0168-8278(22)03111.
    PubMed         Abstract available
    
    

    
    PLoS One

27. LU Z, Li Y, Li AJ, Syn WK, et al
    Loss of GPR40 in LDL receptor-deficient mice exacerbates high-fat diet-induced hyperlipidemia and nonalcoholic steatohepatitis.
    PLoS One. 2022;17:e0277251.
    PubMed         Abstract available
    
    

    
    Transplant Proc

28. BEKKI Y, Fenig Y, Myers B, Florman S, et al
    The Implication of Center Volumes in Donation After Circulatory Death for Liver Transplantation: Donor-Recipient Selection and Outcomes.
    Transplant Proc. 2022 Jul 20. pii: S0041-1345(22)00416.
    PubMed         Abstract available
    
    
29. POHL J, Bischoff P, Oellinger R, Schoening W, et al
    Liver Transplantation and the Use of Metamizole to Treat Drug-induced Liver Injury.
    Transplant Proc. 2022 Aug 3. pii: S0041-1345(22)00422.
    PubMed         Abstract available
    
    
30. NATSUDA K, Soyama A, Hara T, Matsushima H, et al
    The Efficacy of Acoustic Radiation Force Impulse Elastography for Predicting Clinical Outcomes in Living Donor Liver Transplant.
    Transplant Proc. 2022 Aug 3. pii: S0041-1345(22)00441.
    PubMed         Abstract available
    
    
31. AKBULUT S, Isik B, Mehdi Uremis M, Dogan UG, et al
    Tissue Heavy Metals in Liver Diseases.
    Transplant Proc. 2022;54:1859-1864.
    PubMed         Abstract available
    
    
32. DUIZENDSTRA AA, De Knegt RJ, Nagtzaam NMA, Betjes MGH, et al
    Minimal Development of Liver Fibrosis in Adult Tolerant Liver Transplant Recipients Late After Immunosuppressive Drug Weaning and Transplantation.
    Transplant Proc. 2022 Sep 11. pii: S0041-1345(22)00423.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Liver Diseases is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: